5708
Z. Wu et al. / Polymer 53 (2012) 5706e5716
CDCl3,
d
, ppm): 8.53 (d, J ¼ 2.4 Hz, 2H, Hj), 8.21 (dd, J ¼ 9.6, 2.4 Hz,
washed thoroughly with ethanol, and dried under vacuum at
100 ꢀC to produce the corresponding polyimide (R)-7a. The poly-
mer was further purified by reprecipitation from DMAc into
ethanol twice.
2H, Hi), 7.89 (d, J ¼ 8.4 Hz, 2H, He), 7.83 (d, J ¼ 7.8 Hz, 2H, Hd), 7.42
(dd, J ¼ 7.8, 7.2 Hz, 2H, Hc), 7.19 (dd, J ¼ 7.8, 7.2 Hz, 2H, Hb), 7.11 (dd,
J ¼ 8.4, 2.4 Hz, 2H, Hf), 6.83 (d, J ¼ 9.6 Hz, 2H, Hh), 6.79 (d, J ¼ 7.8 Hz,
2H, Ha), 6.57 (d, J ¼ 2.4 Hz, 2H, Hg). 13C NMR (600 MHz, CDCl3,
d
,
(R)-7a. FT-IR (KBr, cmꢁ1): 1788 (asymmetric C]O stretch), 1734
(symmetric C]O stretch), 1377 (CeN stretch), 1258 (AreOeAr),
1142 (CF3), 1053, 744 (imide ring deformation). 1H NMR
ppm): 160.94 (C14), 153.72 (C11), 150.88 (C13), 148.09 (C2), 141.70
(C17), 140.45 (C7), 139.97 (C8), 128.75 (C18), 128.45 (C5), 128.39 (C4),
124.04 (C3),123.81 (C16),122.11 (q, 1JCeF ¼ 271.5 Hz, C20),121.86 (C9),
(600 MHz, CDCl3,
d
, ppm): 7.97 (d, J ¼ 7.8 Hz, 2H), 7.89 (s, 2H), 7.84
120.60 (C10), 120.49 (q, JCeF ¼ 32.3 Hz, C15), 120.32 (C6), 116.75
(d, J ¼ 8.4 Hz, 4H), 7.80 (d, J ¼ 7.8 Hz, 2H), 7.66 (s, 2H), 7.42 (d,
J ¼ 9.0 Hz, 2H), 7.37 (dd, J ¼ 7.2, 7.2 Hz, 2H), 7.13 (dd, J ¼ 7.2, 7.2 Hz,
2H), 7.08 (d, J ¼ 8.4 Hz, 2H), 6.90 (d, J ¼ 9.0 Hz, 2H), 6.77 (d,
2
(C19), 116.70 (C12), 66.00 (C1). MALDI-FTICR MS (m/z): [M]þ calcd for
C39H20F6N2O6, 726.12; found, 726.12. Elemental analysis: Calcd for
C39 H20F6N2O6: C, 64.47%; H, 2.77%; N, 3.86%. Found: C, 64.56%; H,
2.85%, N, 3.81%.
J ¼ 7.2 Hz, 2H), 6.60 (s, 2H). 13C NMR (600 MHz, CDCl3,
d, ppm):
165.77, 165.60, 155.73, 155.00, 150.73, 148.25, 140.77, 139.29, 138.91,
136.03, 132.47, 132.19, 131.23, 128.19, 127.92, 125.62, 125.44, 125.18,
124.25, 124.02, 122.68, 122.36, 121.49, 121.10, 120.06, 118.13, 116.48,
65.95, 65.24.
Optically inactive 2,20-bis(4-nitro-2-trifluoromethylphenoxy)-
9,90-spirobifluorene was synthesized by the same procedure. The
yield was 93%. The melting point was 267e269 ꢀC with pronounced
effervescence at 115 ꢀC and resolidification around 160e170 ꢀC.
(R)-7b. FT-IR (KBr, cmꢁ1): 1783 (asymmetric C]O stretch), 1726
(symmetric C]O stretch), 1376 (CeN stretch), 1260 (AreOeAr),
1138 (CF3), 1053, 743 (imide ring deformation). 1H NMR
2.3.3. (R)-2,20-bis(4-amino-2-trifluoromethylphenoxy)-9,90-
spirobifluorene
(600 MHz, CDCl3,
d
, ppm): 7.92 (d, J ¼ 7.8 Hz, 2H), 7.83 (d, J ¼ 8.4 Hz,
Optically active dinitro compound (R)-5 (5.09 g, 7.0 mmol) and
10% Pd/C (0.10 g) were suspended in ethanol (80 mL) in a 250-mL
flask. The suspension was heated to reflux, and 80% hydrazine
monohydrate (3 mL) was added dropwise to the stirred mixture.
After a further 6 h reflux, the resulting clear, darkened solution was
filtered hot to remove Pd/C, and the filtrate was dried by rotary
evaporation. The crude product was purified by recrystallization
from 1,2-dichloroethane to afford pale-yellow needle-like crystals
2H), 7.79 (d, J ¼ 7.8 Hz, 2H), 7.66 (s, 2H), 7.46 (s, 2H), 7.44(d,
J ¼ 7.8 Hz, 2H), 7.42 (d, J ¼ 7.8 Hz, 2H), 7.37 (dd, J ¼ 7.2, 7.2 Hz, 2H).
6.77 (d, J ¼ 7.8 Hz, 2H), 6.60 (s, 2H). 13C NMR (600 MHz, CDCl3,
d,
ppm): 165.90, 165.80, 161.16, 155.60, 155.02, 150.75, 148.26, 140.78,
138.90, 134.45, 131.27, 128.19, 127.93, 127.15, 126.37, 125.61, 125.45,
124.88, 124.04, 122.74, 121.50, 120.97, 120.13, 120.06, 117.99, 116.49,
114.04, 65.94.
(R)-7c. FT-IR (KBr, cmꢁ1): 1784 (asymmetric C]O stretch), 1730
(symmetric C]O stretch), 1376 (CeN stretch), 1259 (AreOeAr),
1139 (CF3), 1053, 746 (imide ring deformation). 1H NMR
(4.01 g, 86%). mp: 262e264 ꢀC ½a D20
ꢃ
¼ þ67.0ꢀ (c ¼ 0.50 g/dL, DMAc).
FT-IR (KBr, cmꢁ1): 3471, 3386 (eNH2), 1228 (AreOeAr), 1121 (e
CF3). 1H NMR (600 MHz, DMSO-d6,
d, ppm): 7.93 (d, J ¼ 8.4 Hz,
(600 MHz, CDCl3,
d
, ppm): 8.14 (d, J ¼ 7.2 Hz, 2H), 8.10 (s, 2H), 8.00
2H, He), 7.90 (d, J ¼ 7.2 Hz, 2H, Hd), 7.37 (dd, J ¼ 7.8, 7.2 Hz, 2H, Hc),
7.09 (dd, J ¼ 7.8, 7.2 Hz, 2H, Hb), 6.91 (dd, J ¼ 8.4, 2.4 Hz, 2H, Hf), 6.84
(s, 2H, Hj), 6.71 (s, 4H, Hh and Hi), 6.59 (d, J ¼ 7.2 Hz, 2H, Ha), 6.05 (d,
(d, J ¼ 7.2 Hz, 2H), 7.85 (d, J ¼ 7.8 Hz, 2H), 7.80 (d, J ¼ 6.6 Hz, 2H),
7.67 (s, 2H), 7.47 (d, J ¼ 9.0 Hz, 2H), 7.38 (dd, J ¼ 7.2, 7.2 Hz, 2H), 7.14
(dd, J ¼ 6.6, 7.2 Hz, 2H), 7.09 (d, J ¼ 7.8 Hz, 2H), 6.85 (d, J ¼ 9.0 Hz,
J ¼ 2.4 Hz, 2H, Hg), 5.42 (s, 4H, Hk). 13C NMR (600 MHz, DMSO-d6,
d
,
2H), 6.78 (d, J ¼ 7.2 Hz, 2H) 6.61(s, 2H). 13C NMR (600 MHz, CDCl3,
d,
ppm): 158.49 (C11), 150.01 (C13), 147.81 (C2), 145.75 (C14), 142.12
(C17), 140.64 (C7), 135.80 (C8), 128.02 (C5), 127.28 (C4), 123.30 (C3),
123.34 (q, 1JCeF ¼ 271.5 Hz, C20), 122.62 (C18), 121.71 (C9), 121.30 (q,
2JCeF ¼ 30.0 Hz, C15), 120.04 (C6), 118.34 (C19), 116.65 (C10), 116.62
(C12), 110.73 (C18). MALDI-FTICR MS (m/z): [M]þ for C39H24F6N2O2,
666.17; found, 666.17. Elemental analysis: Calcd for C39H24F6N2O2:
C, 70.27%; H, 3.63%; N, 4.20%. Found: C, 70.35%; H, 3.60%; N, 4.16%.
Crystal data: pale-yellow crystal grown during slow crystalli-
zation in ethanol/ethyl acetate (3:1 v/v), 0.34 ꢄ 0.21 ꢄ 0.12 mm3,
ppm): 192.54, 165.73, 155.98, 154.75, 150.81, 148.20, 141.81, 140.74,
139.08, 135.91, 134.80, 131.99, 131.31, 128.23, 127.99, 125.67, 125.05,
124.67, 124.32, 124.07, 122.70, 121.58, 120.84, 120.41, 120.09, 117.65,
116.64, 65.93.
(R)-7d. FT-IR (KBr, cmꢁ1): 1779 (asymmetric C]O stretch), 1726
(symmetric C]O stretch), 1374 (CeN stretch), 1250 (AreOeAr
stretch), 1135 (CF3), 1052, 736 (imide ring deformation). 1H NMR
(600 MHz, CDCl3,
d
, ppm): 7.88 (d, J ¼ 7.8 Hz, 2H), 7.84 (d, J ¼ 8.4 Hz,
2H), 7.80 (d, J ¼ 7.2 Hz, 2H), 7.77 (s, 2H), 7.76 (d, J ¼ 7.8 Hz, 2H), 7.65
(s, 2H), 7.46 (d, J ¼ 8.4 Hz, 2H), 7.37 (dd, J ¼ 6.6, 7.2 Hz, 2H), 7.13 (dd,
J ¼ 6.6, 6.6 Hz, 2H), 7.07 (d, J ¼ 7.8 Hz, 2H), 6.83 (d, J ¼ 8.4 Hz, 2H),
ꢀ
ꢀ
tetragonal P43212 with
a
¼
16.198(2) A,
b
¼
16.198(2) A,
¼ 90ꢀ,
b
¼ 90ꢀ and
g
¼ 90ꢀ, where Dc ¼ 1.374 Mg/
ꢀ
c ¼ 12.285(4) A,
a
m3 for Z ¼ 4 and V ¼ 3223.2 Å3. For crystallographic data for the
6.78 (d, J ¼ 7.2 Hz, 2H), 6.61 (s, 2H). 13C NMR (600 MHz, CDCl3,
d,
structure, see the Supporting Information (Table S1).
ppm): 166.24, 166.16, 155.89, 154.71, 150.81, 148.20, 144.81, 140.78,
139.06, 133.17, 132.72, 131.43, 128.22, 127.96, 125.78, 125.15, 124.59,
124.07, 122.73, 122.09, 121.59, 120.69, 120.45, 120.09, 117.55, 117.49,
116.64, 65.93.
Optically inactive diamine compound 6 was synthesized by the
same procedure, except that it was purified by recrystallization
from benzene. The yield was 89%, mp: 274e276 ꢀC.
2.4. Synthesis of polyimides
3. Results and discussion
A typical polymerization procedure was as follows. To a solution
of 0.9954 g (1.49 mmol) of diamine (R)-6 in 10 mL DMAc in a 50-mL
flask, 0.6634 g (1.49 mmol) of 6FDA was added in one portion. The
solid content of the solution is approximately 10%. The mixture was
stirred at room temperature for 10 h under nitrogen atmosphere to
yield a viscous poly (amic acid) solution. Chemical imidization was
carried out by adding a mixture of acetic anhydride (0.60 mL) and
triethylamine (0.30 mL) into the poly (amic acid) solution. This
mixture was stirred at room temperature for 6 h and then heated at
80 ꢀC for 2 h. After cooling, the viscous solution was added slowly
into ethanol (100 mL). The precipitate was collected by filtration,
3.1. Monomer synthesis
The synthetic route to new optically diamine monomer (R)-6 is
outlined in Scheme 1. The precursor, 9,90-spirobifluorene (1) was
prepared according to literature procedures [44]. On acylation and
oxidation, followed by alkaline hydrolysis, 1 gave (ꢂ)-2,20-dihy-
droxy-9,90-spirobifluorene (4). Tartaric acid derivative [(R,R)-
(þ)-2,3-dimethoxy-N,N,N0,N0-tetracyclohexylsuccinamide ((R,R)-
(þ)-DMTCHS, chiral host)] could selectively recognize (R)-4 (chiral
guest) in the solution of ethanol and formed crystalline complex.
The absolute stereochemistry of the complex was confirmed by